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Abstracts 
 
              Background:  Gestational trophoblastic diseases are characterized   
       by an abnormal trophoblasts proliferation. 
                     Epidemiologically, trophoblastic diseases occur with much greatest 
frequency in the Far East and other parts of the third world than in 
the Western Hemisphere.  The diseases are seen in the teenage 
and premenopausal age groups.   
                   The objective of this study was to report on cases of gestational 
trophoblastic diseases received in the department of histopathology 
at National Health Lab in Khartoum state, its pattern, mode of 
presentation and histopathological features. 
 
                    Methods:  This is a descriptive retrospective study. The slides 
were retrieved from archives and reviewed by the researcher with 
the supervisor. The slides were prepared from tissues fixed in 10% 
formalin and handled according to histological protocol. A hundred 
and nine  cases were included after exclusion of cases with 
deficient records or missed histopathology slides and blocks. 
Clinical information was gathered from the records including the 
age, parity, type of specimen. The data were analyzed using 
computer program (SPSS). 
 
                     Results:  The mean age of patients was 31.5 years, 38% of cases 
occurred in the age group (20-29 years)  followed  by 31% in  the  
age group  (30-39 years). Twenty percent of cases occurred in 
ladies  above  40  years  and  11%  below  20  years. Multiparous 
were the most  affected group (52%) followed by grand multipara 
(31%) Primigravidae were the least affected (17%).Pure vaginal  
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bleeding was the main presentation in 51% and  in 5% of cases  it 
was   associated with  passage  of  vesicles  and  in  1% with  
abdominal  pain. In 10% of cases the diagnosis was made during 
routine U/S follow up. In 32% of cases   there  was  a previous  
history  of abortion.  
                     Microscopically partial mole was the dominant lesion (65%), 
followed by complete mole 28%, choriocarcinoma 4% and invasive 
mole 3%. Cases of  placental  site  trophoblastic  tumors ,  
placental site  nodules ,  epithelioid  trophoblastic  tumors were not 
encountered  in  this  study. 
 
                    Conclusion:  Gestational trophoblastic disease  mostly affects 
multipara in the second and third decades of life. Microscopy partial 
mole was the most common lesion (65%). Vaginal bleeding was 
the main presentation and  abortion was a risk  factor.   
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                 INTRODUCTION & LITERATURE REVIEW 
 
1-1-INTRODUCTION: 
   Gestational trophoblastic diseases are a 
group of lesions ranging from benign to frankly 
malignant. 
All of them are derived from trophoblasts(1), which 
are cells forming the outer layer of a blastocyst.(2)  
They provide nutrients to the embryo and develop 
into a large part of the placenta. 
  Historically these lesions were known since 400 
BC when Hippocrates described the first lesion and 
called it dropsy of the uterus. While in AD 600 
Aetius of Armida described a uterus “filled with 
bladderlike objects,” which probably also 
represented this process. In 1827 Velpeau and 
Boivin first recognized hydatids as cystic dilations of 
chorionic villi. Sanger, in 1889, coined the term 
sarcoma uteri deciduocellulare as a malignant 
tumor derived from the decidua of pregnancy.  
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In 1895, Marchand demonstrated these tumors to 
be the sequelae of pregnancy, abortion, or 
hydatidiform mole and described the proliferation of 
the syncytium and cytotrophoblast. In 1903, 
Teacher confirmed Marchand's work and negated 
Sanger's theory of sarcomatous degeneration of the 
decidua.(3) 
In 1927 a breakthrough in the understanding of 
GTD  happened by the recognition of human 
chorionic gonadotropin, which is highly elevated in 
these conditions and is produced by 
cytotrophoblasts(4), and it was used later in follow 
up of patients, monitoring of treatment and 
detection of relapse. Nowadays ultrasonagraphy 
has an important role in the diagnosis of GTD. 
These lesions are extremely sensitive to 
chemotherapy(5) and folic acid antagonists. 
          1-2- DEVELOPMENT OF TROPHOBLASTICS       
Normally trophoblastic cells exist in two sites, 
either in association with chorionic villi and, this is 
villous trophoblast, or outside the villi and, this is 
extra villous trophoblast. 
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1-2-1-Development of villous trophoblastic cells: 
Embryollogically villous trophoblastic cells 
developed in 3 stages:  
Prelacunar, lacunar and early villous stages 
1-Prelacunar stage: 
It is defined as the period from conception to day 
8. After fertilization of the ovum the zygote 
develops into a blastocst which is a flattened 
vesicle made up of about107-256 cells. The cells 
of the outer wall which surround the blastocystic 
cavity are the trophoblast while the inner cell mass 
on the inner surface is a small group of large cells 
forming the embryoblast. 
The first step in implantation of the blastocyst is 
called apposition, in which the blastocyst is 
oriented, and the embryonic pole attaches to the 
endometrium and thus forms the implantation 
pole(6). This step occurs on day 6-7. 
In the following days, the trophoblastic cells 
proliferate forming double layers that progressively 
invade the endometrial epithelium.  The inner layer 
of the trophoblast is composed of cytotrophoblast 
Please purchase PDFcamp Printer on http://www.verypdf.com/ to remove this watermark.
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and the outer layer which faces the maternal 
tissue is transformed to syncytiotrophoblast by 
fusion of neighboring   cytotrophoblastic cells.  
At the implantation pole the syncytial mass forms 
branching finger like extensions that deeply 
invade, and interdigitate with the endometrium 
.This is the trophoblastic shell(6). (Figure-1a&b) 
2-Lacunar stage: 
This stage starts by the appearance of small 
vacuoles in the syncytiotrophoblastic mass on day 
8. These vacuoles grow forming a system of 
lacunae which are separated from each other by 
bands of syncytiotrphoblast called trabeculae. 
By day 12 the blastocyst is deeply implanted and 
the uterine epithelium closes over the implantation 
site(6). 
The cytotrophoblastic cells extend into the 
trabeculae, and by day 13 reach the trophoblastic 
shell. At this point the trophoblast covering the 
blastocyst is divided into three layers(6): 
(A) -the primary chorionic plate, facing the 
blastocystic cavity. 
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(B)-the lacunar system, including the trabeculae 
(C)-the trophoblastic shell, facing the 
endometrium. 
(A)The primary chorionic plate: 
The primary chorionic plate is composed of 
cytotrophoblast  covered  by syncytiotrophoblast 
on the maternal side. On day 14, it is transformed 
into the triple layered chorionic plate by spreading 
of embryonic mesenchyme around the inner 
surface of the cavity and the cytotrophoblast layer. 
At this time the first villous outgrowths from the 
trabeculae start. The trabeculae are henceforth 
called the villous stems, which later become the 
stem villi. 
The lacunar system is transformed into the 
intervillous space. So the chorionic plate serves as 
a base from which the villous trees are 
suspended6. 
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(B)-Lacunar system: 
It lies below the primary chorionic plate. At the 
luminal surface of the lacunae the 
syncytiotrophoblast is present with underlying 
cytotrophoblast. Below the cytotrophoblast and 
facing the endometrial connective tissue is an 
additional discontinuous layer of 
syncytiotrophoblastic elements(6). 
(C)-Trophoblastic shell: 
As the cytotrohoblast expands into the trabeculae, 
the distal ends of the trabeculae join together and 
form the outermost layer of the trophoblastic shell. 
Initially this is a syncytiotrophoblastic structure but 
as the cytotrophoblast reaches the shell on day 15 
the shell becomes more heterogeneous. 
From day 22 onward the term trophoblastic shell is 
usually replaced by basal plate, a term that 
includes the base of intervillous space together 
with all placental and maternal tissues that adhere 
to it after parturition(6). (Figure-1c&d) 
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3-The early villous stage : from day 13-28  
 Is marked by the presence of the primary villi 
which are composed only of an outer 
syncytiotrophoblast layer and a core of 
cytotrophoblast .They develop as the 
cytotrophoblast invades the trabeculae and the 
trophoblastic sprouts grow into the lacunae. 
Primitive villous trees are formed by proliferation 
and branching of the primitive villi. The stems of 
these trees are derived from the trabeculae. The 
villi that keep their contact to the trophoblastic 
shell are known as anchoring villi. (Figure-1c&d) 
The secondary villi are formed as the 
mesenchymal layer of the secondary chorionic 
plate invade the primary villi.  They consist of an 
outer layer of syncytiotrophoblast, an inner layer of 
cytotrophoblast and core of connective tissue. 
Within few days the mesenchyme reaches the tip 
of the villi(6). (Figure-1e&f) 
Tertiary villi are marked by the appearance of 
capillaries in the villous stroma. These capillaries 
appear on day 18-20 and are derived from the 
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hemangioblastic progenitor cells, which locally 
differentiate from the mesenchyme. Complete 
fetoplacental circulation is established, at the 
beginning of the fifth week, by fusion of capillary 
segments forming a capillary bed. Fetal and 
maternal blood comes in contact with each other 
as soon as fetoplacental circulation is established 
but the two blood streams are separated from 
each other by a placental barrier which is 
composed of syncytiotrophoblast, cytotrophoblast, 
basal lamina, connective tissue and fetal 
endothelium(6). 
From the second month and beyond, the mean 
villous diameter decreases, and the capillaries are 
more numerous and closer to the villous surface(6).  
 
1-2-2-Development of Extra Villous Trophoblast 
and Phenotypes 
            Extra villous trophoblast is a general term 
for a group    of  trophoblastic cells formed from 
the remainder of the trophoblasts in the pre 
lacunar stage, not used in villi formation and 
Please purchase PDFcamp Printer on http://www.verypdf.com/ to remove this watermark.
 ϭϬ 
 
residing outside the villi. They are the basic 
material for the development of all non-villous 
parts of the placenta: chorionic leave, marginal 
zone, chorionic plate, basal plate, cell columns, 
septa and cell islands. 
           The extra villous trophoblasts are 
subdivided according to location and differentiation 
into: 
1-extra villous syncytio trophoblast: are syncytial 
remainders, mostly at the inter villous surfaces of 
all non villous parts 
2-multinucleated trophoblastic giant cells: deeply 
invasive multinucleated elements, probably 
derived from syncytial fusion of invasive extra 
villous cytotrophoblasts 
3-extra villous cytotrophoblast: all mononuclear 
cytotrophoblast outside the villi 
4-proliferative phenotype of extra villous 
trophoblast: proliferating stem cells resting on or 
near the basal lamina facing the villous or 
chorionic stroma 
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5- interstitial trophoblast: all trophoblast cells which 
do not invade the uteroplacental vessels 
6- endovascular trophoblast: trophoblastic cells 
that invade the walls and lumina of uteroplacental 
vessels 
7-intra mural trophoblast: invasive trophoblastic 
cells infilterating the walls of uteroplacental vessels 
8-intra arterial trophpblast : invasive trophoblast 
cells replacing endothelium and forming 
intraluminal plugs in uterplacental vessels (7-8) . 
 
1-3-Histology of trophoblastic cells: 
Syncytiotrophoblast cells: 
On light microscopy, the syncytiotrophoblast cells 
are large multinucleated cells with less distinct cell 
borders and dense eosinophilic cytoplasm. Mitotic 
figures are not identified. In early pregnancy they 
appear as one layer surrounding the 
cytotrophoblast while in late pregnancy they have 
variable thickness. It may be focally thinned out to 
almost invisible forming what is known as the 
vasculosyncytial membrane. In some areas it may 
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appear as a single cell layer, while in other areas 
the nuclei may be piled up forming syncytial 
knots(9).  
Ultrastructurally they are highly complex featuring 
irregular nuclear outlines and contain 
desmosomes, thick bundles of tonofilaments and 
abundant microvilli on the cell surface(9). 
Immunohistochemistry reveals high reactivity for 
HCG and Human Placental Lactogen(10). 
Cytotrophoblastic cells (the Langhans’ cells): 
In early pregnancy they form a continuous layer 
beneath the syncytiotrophoblastic cells. In late 
pregnancy as the villi surface expands, the 
cytotrophoblastic cells become widely separate 
and they form a discontinuous layer. 
At all stages of pregnancy, the cytotrophoblastic 
cells have the following features on the light 
microscope: 
They are uniformly oval to polygonal containing 
single nuclei with dispersed chromatin and scanty 
clear cytoplasm. The cells have distinct cell 
borders9. Mitoses may be seen. 
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Ultra structurally, the cells have smooth nuclear 
outlines and contain less numerous desmosome 
and they neither contain intermediate filaments nor 
microvilli on the cell surface(9). 
Immunohistochemically the cells are not reactive 
to HCG and HPL(10). 
Extra villous trophoblast:  
Formerly was known as intermediate trophoblast. 
These cells are variably shaped round, polyhedral 
and spindle. They are generally mononucleated 
but occasionally may be multinucleated. The cell 
border is less distinct. They contain abundant 
amphophilic cytoplasm(11). Mitoses may be seen. 
Ultra-structurally they have intermediate 
complexity, intermediate nuclear outline, less 
numerous desmosomes, less abundant micovilli 
on the cell surface and para nuclear intermediate 
filaments. 
Immunohistochemically the cells are strongly 
positive for HPL  and   variably   reactive   with  
HCG(10).  
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1-4-Functions of trophoblast: 
Trophoblasts are specialised cells that play an 
important role in embryo implantation and 
interaction with the decidualised maternal 
endometrium .  
The syncytiotrophoblast is involved in maternofetal 
transfer mechanisms which include:  
1-catabolism and synthesis of proteins and lipids. 
2-synthesis of hormones such as: 
a- Human chorionic gonadotropin. 
b- Human chorionic somatotropin. 
c- Human placental lactogen. 
d- Human growth hormones. 
3- diffusional transfer of gases and water. 
4- active transfer of amino acids and electrolytes9. 
The cytotrophoblast is considered to be the 
trophoblastic stem cell.   
                                 
1-5- Trophoblastic Diseases  
It is an umbrella term for a group of histologically 
distinct    disorders that arise from trophoblastic 
tissue. They are also referred to as gestational 
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trophoblastic tumors (GTTs) and gestational 
trophoblastic neoplasia (GTNs); they may be 
benign or malignant diseases 
 All are characterized by: 
1-production of (HCG)  
2-sensitivity to chemotherapy 
 
1-6-Classifications of GTD: 
GTD are primarily classified into: molar and non 
molar. Molar lesions include complete hydatidiform 
mole, partial hydatidiform mole and invasive mole.  
Non molar diseases includes choriocarcinoma, 
placental site trophoblastic tumor, epithelioid 
trophoblastic tumor and placental site nodule(12). 
 -Clinical classification: 
According to the National Institute of 
Health(NIH)(13), GTD are divided into: 
1-Gestational trophoblastic disease (benign GTD) 
a- Complete hydatidiform mole. 
b- Partial hydatidiform mole. 
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2-Gestational trophoblastic tumor (Malignant GTD) 
-Non metastatic 
-Metastatic. 
        1-6-2-Modified WHO classification-(2003) 
Hydatidiform mole 
            Complete mole 
            Partial mole 
       Invasive mole 
       Metastatic mole 
Trophoblastic neoplasms 
        Choriocarcinoma 
        Placental site trophoblastic tumor 
        Epithelioid trophoblastic tumor 
Non- neoplastic, non molar trophoblastic lesions 
        Placental site nodule 
        Exaggerated placental site(14) . 
   1-7- EPIDEMIOLOGY 
The incidence rates of GTD are difficult to adjust 
because of the limitations in the methodology of 
these studies. Some studies of incidence rates 
have used hospital based rather than population 
based data, which may result in over reporting.  
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 The overall reported incidence of hydatidiform 
mole and choriocarcinoma varies widely 
throughout the world, being highest in developing 
countries (Asia, Africa and Latin America) and low 
in developed countries (North America, Europe 
and Australia).  
 In Asia, the incidence rate of hydatidiform mole 
can be as high as 1 in 500 pregnancies. In USA 
and Europe it varies between 1 in 1000 to 1 in 
2000 pregnancies. 
Based on recent studies the world wide incidence 
rate of complete and partial mole is 1 per 1500-
2000 pregnancies and 1 per 700 pregnancies, 
respectively.  
In choriocarcinoma, as molar disease, there is 
marked regional variation in incidence rates. In 
Nigeria it is the third most common malignant 
tumor, at one institution, rankling behind breast 
and cervical carcinoma. In USA and Europe the 
frequency is 1 in 20000 to 1 in 40000(15).  
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Risk factors: 
1- Age: GTD is a disease of reproductive age 
being higher in teenagers and women above 40 
years. There is a 10- fold rate among women 
above 40 years age(16). 
 Maternal age has no effect on partial molar 
pregnancy. Neither paternal age nor race seems to 
affect the risk of developing hydatidiform mole. 
Placental site trophoblastic tumor and epithelioid 
trophoblastic tumors occur infrequently in 
postmenopausal women(17). 
 
2- Race: GTD has a higher incidence in Africans 
and Asians. 
3- Parity: GTD is decreased in women who are 
parous with multiple term pregnancies and live 
births. A case control study demonstrated that the 
risk factors for partial molar pregnancy include 
irregular cycles, only male infants among prior live 
births and oral contraceptive pills use for more 
than 4 years  
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4- Blood group: Women with recurrent molar 
pregnancies have blood group B. In Japan, 
patients with lower incidence of GTD are Rh -ve 
blood type compared to normal population.  
5- Reports are inconclusive, older reports 
describing a lower incidence of GTD among 
women with high carotene intake(16). 
6- Smoking: is associated with an increased risk of 
GTD. 
7-Previous abortion: History of prior spontaneous 
abortions is more common in patients with 
complete molar pregnancy and choriocarcinoma 
than normal pregnancies. (17)  
8- Past molar pregnancy: Women who have had 
one hydatidiform mole are at increased risk of 
having another.  
 
1-8-Clinical Features: 
Clinically, patients presented with a history of 
amenorrhea followed by:  
- Vaginal bleeding which may be significant 
and prolonged, leading to significant anemia. The 
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patient may occasionally experience the passage 
of pathognomic grape-like vesicles. 
- Uterine size larger than gestational age 
- Toxemia is classically associated with 
hypertension, proteinurea, and hyper-reflexia. 
When it happens in early pregnancy, GTD should 
be ruled out 
- Hyperemesis is more likely to happen in 
patients with markedly elevated levels of HCG. 
- Hyperthyroidism may be associated with 
classical signs of tachycardia, tremors, and warm 
skin. 
- Theca lutein ovarian cysts are related to high 
levels of HCG(18). They resolve spontaneously 
after successful treatment of GTD. 
 
  1-9-Pathology:                   
Trophoblastic diseases are either derived from villous 
trophoblast, as in molar pregnancy or choriocarcinoma 
or from extra villous trophoblasts as in placental site 
trophoblastic tumor, exaggerated placental site, and 
placental site nodule.  
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Hydatidiform molar pregnancy: 
Traditionally, it is subdivided into complete and partial 
molar pregnancies. They differ in both gross and 
microscopic appearance as well as in molecular level. 
Grossly complete hydatidiform mole shows, uniformly 
large grape like, transparent vesicles(Figure 2&3), and 
no fetus or gestational sac in most cases, while partial 
hydatidiform mole shows large hydropic vesicles 
admixed with nonmolar placental tissue, and a fetus 
with developmental abnormalities, may be present(19).  
 Microscopic findings: 
The microscopic findings of complete mole shows 
enlarged villi with generalized hydropic changes and 
central cisterns. Marked hyperplasia of both villous 
cytotrophoblast and syncytiotrophoblasts is seen.  
Hyperplasia of intervillous and implantation 
trophoblasts as well as striking cytological atypia are 
seen. There are no fetal parts(19) (Figure4). On the 
other hand examination of partial molar pregnancy 
may show enlarged villi admixed with small and normal 
sized ones or enlarged villi with scalloped border and 
trophoblast inclusions. Less frequent or prominent 
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cavitations than in CHM are seen. Mild or focal 
syncytiotrophoblastic hyperplasia with lacy or moth 
eaten appearance. Evidence of fetal development 
including nucleated RBCs in villous capillaries, 
chorionic plate, amnion, cords, or fetal tissues(19) 
(Figure 5) 
On molecular basis cytogenetic studies show that 
complete mole has a normal diploid DNA content 
derived from the paternal genome. Most complete 
moles  are 46 XX.  
Complete molar pregnancy results from either: 
1- Fertilization of an empty ovum (lost its nucleus) by 
a single sperm, then due to subsequent duplication of 
the haploid spermatozoal component, diploid genotype 
result. or 
2- Fertilization of an empty ovum by two sperms. 
Fusion of the two male pronuclei results in 46 XY 
genotype which is rare and constitutes about 15% of 
complete molar pregnancies.  
Moles with 46YY are not found and it is assumed to be 
a lethal condition. Triploid and tetraploid are very rare 
in complete mole. 
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The partial mole is usually triploid with two sets of 
chromosomes of paternal origin and a haploid 
maternal set(20).Partial mole is a result of fertilization of 
an ovum by two sperms resulting in triploid kryotype 
69XXX. 69XXY.or rarely 69XYY(21). 
Figure 2: Gross appearance of intrauterine molar 
pregnancy 
 
 
 
 
 
 
 
Figure 3: Gross appearance of the grape like chorionic villi 
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Figure 5: Microscopy of partial molar pregnancy (H&E) 
 
Figure 4: Microscopic appearance of complete molar 
pregnancy(H&E 
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Invasive Mole: 
 
      Grossly appears as small area of haemorrhage or 
multiple vesicles in the myometrium, or in florid cases 
as hemorrhagic cavities deeply and extensively 
invading the myometrial wall(22). Diagnoses can only 
be made in a hysterectomy specimen. 
Microscopically, characterized by invasion of the 
myometrium or its vascular spaces by molar villi with 
proliferating cyto- and sncytio- trophoblasts without 
intervening decidua (Figure 6&7). 
 
 
Figure 6: gross appearance of uterus with invasive 
mole 
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Figure 7: Microscopy of invasive mole showing villi within 
the myometrium 
 
 
Choriocarcinoma: 
         Grossly, dark red, hemorrhagic masses, friable 
on cut surface with variable necrosis. 
  Microscopically, the tumor has a biphasic growth 
pattern with syncytiotrophoblast cells surrounding 
groups of cytotrophoblast cells(23). The 
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syncytiotrophoblastic cells have abundant basophilic 
cytoplasm and multiple large irregular hyperchromatic 
nuclei. The cytotrophoblastic cells have clear 
cytoplasm and large atypical and vesicular nuclei with 
clumped chromatin and prominent nucleoli. Frequent 
mitoses are seen in these cells. 
Minor components of intermediate trophoblasts are 
seen. 
The tumor shows prominent vascular invasion with 
hemorrhagic lakes and extensive necrosis. 
No chorionic villi(23) are seen in gestational 
choriocarcinoma (Figure 8&9). 
 
          
Figure8: Uterus; gross appearance of         
choriocarcinoma 
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Figure 9: Microscopic appearance of choriocarcinoma 
 
Placental site trophoblastic tumor: 
  It is a neoplasm of non villous trophoblast derived 
from placental site representing the malignant 
counterpart of the exaggerated placental site. 
 Grossly it is well circumscribed with ill defined 
borders. The cut surface is soft, yellow tan with focal 
hemorrhage or necrosis(24). 
Microscopically, the tumor is characterized by: 
 Sheets, and at the periphery, tumor cells infiltrate 
between muscle fibers in sheets, nests, cords, or singly. 
Invasion and replacement of vascular walls by 
intermediate trophoblast admixed with fibrinoid material is 
seen.  These cells are mononucleated or less frequently 
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binucleated or multinucleated.  The cytoplasm is 
amphophilic or eosinophilic but less frequently may be 
clear. The nuclei are small to large irregular 
hyperchromatic with variable degree of 
pleomorphisms(24). Rare syncytiotrophoblast cells. 
Average mitotic figures 2-5/10 HPF are seen (figure10). 
 
 
Figure 10: Microscopic appearance of placental site 
trophoblastic tumor 
Placental site nodule: 
None neoplastic lesion of intermediate trophoblast 
derived from chorion leave(fetal membrane) 
Gross Findings: 
1-small up to 1 cm 
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2-if visible, yellow, tan or hemorrhagic on cut section. 
Microscopic findings: 
1- Well circumscribed lobulated border. 
2- Nests, cords or single cells embedded in abundant 
dense eosinophilic extra cellular matrix. 
3- Small round extensions with pseudo infiltrative 
growth sometimes present at the periphery. 
4-Abundant eosinophilic or vacuolated cytoplasm, small 
and vesicular, or large and irregular nuclei with 
degenerative chromatin pattern. (25) 
5- No mitotic activity.(figure11)  
 
 
Figure 11: Microscopic appearance of placental site 
nodule 
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Epithelioid trophoblastic tumor: 
It is a neoplasm of intermediate trophoblast derived 
from the chorion leave( fetal membrane)  thought to 
represent the malignant counterpart of placental site 
nodule. 
Grossly, it is a discrete expansile nodule measuring up 
to 5 cm.(26) On cut sectionis solid, tan to brown often 
with areas of hemorrhage and necrosis. 
Microscopy: 
1-well circumscribed expansile margin 
2-The tumor cells form sheets, nests, islands or nodules 
with blood vessels present in the center. 
3-Extensive geographic necrosis in between nests, 
islands, and nodules. 
4-Intimate association of cells with eosinophilic, hyaline 
like material and necrotic material. 
5-Mononucleated cells with uniform nuclei and 
eosinophilic and clear cytoplasm. (Figure12&13) 
6-Average mitotic index2/10 HPF(range 0-9) (13).  
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Figure 12: Gross appearance of epithelioid trophoblastic tumor 
 
 
Figure 13: Microscopy of epithelioid trophoblastic tumor 
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1-10-Diagnosis:  
     Usually straightforward in clinically suspected cases. 
Ultrasound has an important role in diagnosis but 
definitive diagnosis depends on histopathology. 
1- Clinical history. 
2- Laboratory investigations : 
    - HCG, it is a placental glycoprotein composed of two 
dissimilar subunits alpha and beta. Several forms exist, 
including at least six major variants of HCG detected in 
serum: hyperglycosylated, nicked, HCG missing the B-
subunit C terminal segment, free B subunit, nicked free 
subunit, and free alpha subunit. In urine these samples 
plus urine B-core fragments exist(27). 
So HCG can be measured as: 
   A- Serum HCG: markedly elevated in complete molar 
pregnancy with levels more than 100000 m IU/ml. 
However patients with partial mole are less likely to 
present with very high levels of HCG. Patients with 
placental site trophoblastic disease can present with 
normal levels of HCG.  
      B- Urine HCG: It is of limited uses because of high 
false positive results(28). 
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-HPL, is present in tumor cells on immunohistochemical 
staining, but cannot be used as a tumor marker.  
3-Radiological diagnosis: 
- Ultrasound: very sensitive, especially  trans 
vaginal. Complete mole appear as a complex 
echogenic, intrauterine mass containing many small 
cystic spaces, forming what is known as snow storm 
pattern. The partial mole shows two characteristic 
features:    
A- The ratio of transverse to anterio posterior dimension 
of gestational sac is greater than 1.5.                                                            
B- Irregular appearance with cystic changes in the 
tissues surrounding the gestational sac(16)show storm 
appearance. 
4-Investigations of metastasis:  
Chest X ray, CT scan of the chest, Abdomen, Pelvis 
and CT scan, MRI of the brain. Some theories suggest 
that measurement of  HCG in the CSF is of value in 
detection of brain metastasis. 
5-Immunohistochemical studies: 
Have value in non molar conditions especially in its 
differentiating from non trophoplastic conditions 
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 Choriocarcino
ma 
PST
T 
Epithelioid 
trophoblas
tic tumor 
Nontrophoblas
tic uterine 
tumors 
HCG +++ +/- +/- +/- 
Inhibi
n-a 
++ ++ ++ - 
Hpl + ++ +/- - 
PLAP +/- ++ - +/- 
Mel-
CAM 
++ +++ +/- - 
Kerati
n 
+++ +++ +++ +++ 
EMA + ++ ++ ++ 
p63 + - +++ + 
 
Table (1) 
Immunohistochemical studies in non molar and 
trophoblastic conditions(29) 
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In molar pregnancy it is of limited value because of 
immunohistochemical phenotype similarity to 
placental tissue. Cytotrophoblasts are typically 
positive for cytokeratins and CD 10 but negative for 
HCG, inhibin and HPL , while syncytiotrophoblast  
are strongly positive for HCG. PLAP, inhibin and 
CD10 and weakly positive for HPL(30)          
6-Cytogenetic studies are usually done in research 
to differentiate between complete mole which is 
diploid and partial moles which is triploid(31).  
 
1-11-STAGING: 
There many systems have been used for the 
staging of GTD, include: 
· The National Institute of Health (NIH) System. 
· The World Health Organization (WHO) scoring 
System. 
· The Federation of Gynecology and Obstetrics 
(FIGO) staging system. 
· The (TNM) staging system. (32) 
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1-11-1 The National Institute of Health (NIH) 
System: 
This system was introduced in 1970 on the basis of 
an analysis of patients treated for GTD. Patients are 
divided into: 
 Group I: Non metastatic disease, no evidence of 
disease outside the uterus. 
Group II: Metastatic, any disease outside the uterus. 
This group is further divided into good prognoses 
metastatic disease and poor prognoses metastatic 
disease on the basis of factors that correlated with 
poor response to initial single agent chemotherapy. 
A- Good prognosis metastatic disease(32). 
  1-duration of disease (last pregnancy) < 4 months 
  2-low pretreatment HCG titers < 100000IU/24h in 
urine or <     40000       mlU/ML in serum                
3- No metastases to brain or liver. 
4- No significant prior chemotherapy 
B- Poor prognosis metastatic disease(33). 
1- Duration of disease (last pregnancy) >4 months. 
2- High pretreatment HCG titer > 100000IU/24h in 
urine or >40000       mlU/ML    in     serum 
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3- Brain or liver metastases. 
4- Significant prior chemotherapy. 
5- Term pregnancy. 
 
1-11-2 The World Health Organization (WHO) 
scoring System: 
      This system is helpful in identifying which 
patients would benefit from single agent or multiple 
agent chemotherapy and also is more predictive of 
the clinical outcome. Patients with a score of 8 or 
greater are considered to be at high risk and more 
likely to require combination chemotherapy to 
achieve complete remission. Patients with score less 
than 8 are considered to be at low risk and would 
benefit from single agent chemotherapy. 
 WHO Scoring System: (33) 
Prognostic Factor Score  
Age 
Less than 39 years  0  
Greater than 39 years  1.  
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                  Antecedent pregnancy  
Hydatidiform mole  0  
Abortion  1  
Interval between end of antecedent pregnancy 
and start of chemotherapy. 
<4 months  0  
4-6 months  1  
7-12 months  2  
> 12 months  4  
HCG (IU/ml) 
< 1000  0  
1000-10,000  1  
10,000-1,00,000  2  
>1,00,000  4  
Prognostic factor  Score  
               ABO Groups (female x male)  
Ox A or AxO  1  
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1-11-3- FIGO staging system:     
 Is an anatomic staging system: 
Stage I: Limited to uterine corpus. 
StageII: Extended to the adnexia, outside the uterus but 
limited to the genital structures. 
Stage III: Extends to the lung with or without genital 
tract involvement 
Stage IV: All other metastatic sites. 
1-11-4-The TNM staging system: 
This system was introduced by AJCC 
TNM definitions:  
-Primary tumor (T)  
 -TX: Primary tumor cannot be assessed.  
- T0: No evidence of primary tumor.  
      
B or AB  2  
               Largest tumor including uterine  
3-5 cm  1  
> 5 cm  2  
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      -T1: Disease limited to uterus.  
       -T2: Disease outside the uterus but limited to       
genital structures (Ovary, tube, vagina, broad 
ligaments)  
       -M0: No clinical metastasis  
-M1a: Lung metastasis  
-M1b: All other distant metastasis 
  
AJCC stage groupings:  
Stage IA: T1, M0, no risk factors.  
Stage IB: T1 M0 one risk factors. 
Stage IC: T1 M0 two risk factors  
Stage IIA: T2 M0 no risk factors.  
Stage IIB: T2 M0 one risk factor.  
Stage IIC: T2 M0 two risk factors  
Stage IIIA: Any T, M1a no risk factors.  
Stage IIIB: Any T, M1a one risk factor.  
Stage IIIC: Any T, M1a two risk factors.  
Stage IVA: Any T, M1b no risk factors.  
Stage IVB: Any T M1b one risk factor.  
Stage IVC: Any T, M1b two risk factors(34).  
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1-12-Treatment: 
1-Initial Management: 
The primary treatment of patients with molar pregnancy 
is evacuation of the uterus. Suction curettage is the 
method of choice in complete molar pregnancy. Medical 
termination of complete molar pregnancy should be 
avoided when possible due to risk of trophoblastic 
tissue embolization. In partial mole suction and 
curettage may be limited by the presence of fetal parts 
and therefore medical termination may be necessary. 
    2-Initial assessment: 
  Patients are followed-up for six months. This follow up 
involves periodic assays of urine and serum HCG initially 
weekly reduced to monthly depending on the rate of HCG 
fall. If the level of HCG has fallen to normal within 8 
weeks of uterine evacuation then marker follow up can 
safely be reduced to 6 month in total. However, if HCG 
levels remain elevated beyond 8 weeks follow up is 
continued until the HCG level is normal and for 6 months 
thereafter. 
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3- Treatment of persistent GTD: 
-Second uterine evacuation may be performed provided 
that:  
  A- HCG elevation is low. 
        B- There is significant amount of abnormal 
intrauterine   tissue on repeat U/S 
-Chemotherapy: 
Is required in 20% of complete mole and 0.5% of partial 
molar pregnancies. Indication for chemotherapy are: 
-Serum HCG >20000 IU/L after one or two uterine 
evacuations. 
-Static or rising HCG levels after one or two uterine 
evacuations. 
-Persistent HCG elevations 6 months postuterine 
evacuations. 
-Persistent uterine bleeding with raised HCG levels. 
-Pulmonary metastasis with static or rising HCG. 
-Metastasis in liver, brain or GIT. 
Please purchase PDFcamp Printer on http://www.verypdf.com/ to remove this watermark.
 ϰϰ 
 
-Histological diagnoses of choriocarcinoma. (35) 
Based on the WHO scoring system, patients with a 
score of <6 are treated by single agent chemotherapy, 
while patients with a score >7 are treated by a 
combination of chemotherapeutic agents. It is unusual 
to use radiotherapy, with exception to brain and liver 
metastases where it is used in combination with 
chemotherapy. 
4-Hysterectomy: 
It continues to play an important role in the management 
of persistent GTD especially in those countries where 
there are problems with patients surveillance and 
provision of chemotherapy. (30) 
Indications for hysterectomy are: 
- Where intractable hemorrhage is present. 
- In the presence of residual uterine or pelvic 
tumor mass following adequate chemotherapy 
- In cases of placental site trophoblastic 
tumor.(35) 
- Hysterectomy for disease confined to uterus in 
women who have completed child-bearing 
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-Resection of chemotherapy resistant 
nodules(36). 
      
         1-13-PROGNOSIS and FOLLOW UP: 
 
-During treatment: 
Prior to each cycle HCG, full blood count, renal and 
liver function tests are checked. 
-Following completion of treatment: 
Once treatment is concluded serum HCG is measured:  
A-Weekly for the first 6 weeks 
B-Monthly for the subsequent 6 months 
C-If values remain normal; follow up with periodic urine 
HCG for life. 
-Conception: 
All patients are advised to avoid the use of estrogen 
containing oral contraceptive pills whilst HCG levels are 
elevated as there is a theoretical risk of inducing 
metastatic or drug resistance disease. All patients are 
advised to avoid using intrauterine contraceptive 
devices until normal menstrual cycles are re-
established. 
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-Pregnancy: 
Patients are advised not to conceive for at least 12 
months from the conclusion of their treatment. There is 
a risk of teratogenicity resulting from cytotoxic 
chemotherapy and secondly the risk of recurrent GTD is 
greatest during this time. (37) 
 
1-14-OBJECTIVES 
1-14-1- General objective: 
 To study cases of GTD received in the 
Department of Histopathology at NHL Khartoum state.  
1-14-2-Specific objectives: 
1. To study the pattern of occurrence of GTD in 
relation to age, mode of presentation and parity 
  
2.  To study the histopathological features of GTD.  
                                      
3.   To study the percentage incidence of each 
histological  type  in relation to the total number  
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MATERIALS & METHODS 
 
2.1. Study design:  
The study is a descriptive retrospective recorded data –
based study. 
2.2. Study area: 
The study was conducted at the Department of 
Histopathology NHL, which provides nationwide 
diagnostic services as well as training and research 
services. 
2.3. Study population: 
Cases diagnosed at the department between January 
2007- December 2010. 
2.4. Inclusion criteria: 
Case with complete records and available histological 
slides or paraffin wax embedded blocks. 
2.5. Exclusion criteria: 
Case with deficient record (missed request form) or 
missed histopathology slides and blocks. 
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2.6. Data collection:   
Clinical data was collected from patients request forms 
in questionnaire containing the age, parity, type of 
specimen & microscopic features. 
The slides were retrieved from the archives and revised 
under supervison to confirm the diagnosis of gestational 
trophoblastic lesions and determine the histological 
type.  The slides were prepared from tissue fixed in 
10% formalin and handled according to histological 
protocol.  
2.7. Data analysis: 
The data was analyzed electronically using computer 
program (SPSS).Chi squire test was calculated to 
compare the association. 
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                  3- RESULTS AND ANALYSIS 
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                              4- 1-DISCUSSION 
 
In  this   study 109  cases  were  reviewed  and   showed 
that  the  age   of  the  patients  ranged   between 14-55 
years,  and  the  mean  age  was  31.5  years   this coincides 
with  a  study  done  in  Nigeria  by  SU  Marma  and  his 
colleague (38) in  which  the  mean  age  was  31  years,  but  
it varies  from  other  studies  as  in  south  Africa,  where 
Moodley  M  and  his colleagues(39) found  the  mean  age  of 
patients  to  be  28.5  years.  In  the  study  of  Razieh 
Mohammed  and  her  colleagues  the  mean  age  in  Iran 
was  27.6  years(40).  In  this  study  most  cases  (38%),  
occurred  in  the  2nd  decade  (20-29 years)  followed  by  
the  3rd  decade  of  life  (30-39 years)  and  this  coincides  
with  studies  of  Dr.  Sajjanshetty   Shalini(41)  from  India  
and  Aligbe  J.u.  and  colleagues(41) from  Nigeria . Thirty 
one percent  of  cases  occurred  in  the  extremities  of  
reproductive  age  and  are  distributed  as  follow (20%)  in 
ladies  above  40  years  and  (11%)  below  20  years.  The  
cases  occurred  in  upper  limit  of  the  age  in  this  study  
group  was  higher  than  the  study  of   Razieh   
Mohammed   and colleagues  in  Iran(40)  (18.9%)   and   
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lower  than  the  result  of   Tariq  Kashoggi study  in  KSA(43)  
where  he  found  that  30%  of  all  cases  present  above  
40  years.  Locally  it  generally  coincides  with  the  only  
study  done  in  Sudan  by  Sana  Bakery Mustafa(44)  (Figure 
No.14). 
Relation  to  gravidity  (28  cases  were  excluded  from  the 
study  due  to  incomplete  information  in  records  and  
they  represent  25.6%  of  cases)  revealed  that  the 
gravidity  ranged  from  primigravida  to  gravida  13.  The 
majority  of  cases  occurred  in  gravida  between  2-4  
which represent  (52%),  followed  by  grand  multipara  
(31%), especially  in  gravidity  between  5-8,  in  which  
(17%)  of cases  occur.  Primigravida  were  the  least  
group  of patients   associated  with  GTD,  where  (17%)  of     
cases occur  (Figure 15).  
There  are two  studies  mentioned  by  Sajjanshetty 
Shalini(41)  from  India  and  Tariq  Kashoggi(43)  from  KSA 
which  coincide  with  our  study  in  which  GTD  commonly  
occurred  in  the  2-4th  pregnancies  (42%&52%  
respectively).  On the  other  hand,  this  study  differs from 
the aforementioned  studies  and  another  study  by  
Razieh  Mohammed(40)  and  her  colleagues  in  Iran,  who 
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found  that  PG  was  the  second  most  common  affected  
group  (36%).  In  contrast  we  found it  in grand multipra 
(31%).  The  study  also  showed  that  in  (68%)  of  cases 
there   was no  history  of  previous  abortion,  while   in  the 
rest  of  the  cases  (32%)  there  was  a previous  history  
of abortion  and  the number  of  abortions  ranged  from 1-4 
(Figure No 16). This  coincides  with  Moodley  M  &  his 
colleagues (39)study  in  South  Africa  (33%),  and  is  
slightly higher  than  the  local  study  of   Sana(44)&  the  
study  of   Razieh  Mohammed(40)  in  Iran  (28% for each) 
Clinically  most  cases  presented  by  vaginal  bleeding 
(51%) ,  in (5%)  the  vaginal  bleeding  was  associated 
with  passage  of  vesicles  and  in  (1%) the  vaginal 
bleeding  was  associated  with  abdominal  pain. In our 
study  (10%)  of  cases  were  diagnosed  by  U/S  during 
routine  follow  up.  One  case  was  previously  diagnosed 
as  molar  pregnancy  and  presented  by  rising  HCG. 
Thirty two  percent  of cases  were  mentioned just as  
molar pregnancies  in request forms.  Due  to  deficient  
clinical information  in  the  records,  three  cases  (2.5%)  
were excluded  from  the  analysis .  
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These  results  of  presentation  coincide  with  the  local 
study  of  Sana(44),  where  vaginal  bleeding  was  the major  
presenting  feature  (78%);  on  the  other  hand passage  of  
vesicles  occurs  in  5%  of  cases,  which  is slightly  higher  
from  the  same  study  (3%).  Studies  by BM,  IU  Takai  
and  their  colleagues(45) from  Nigeria  &  Sajjanshetty  
Shalini(41)  from  India  showed  abnormal vaginal  bleeding  
in  (100%),  but  SU  Marma  and  her colleagues(39)  in  
South  Africa  showed  that  abnormal vaginal  bleeding  
occurs  in  (73.3%),    Sajjanshetty Shalini(41)  in  India  also  
mentioned that in 64%  of  the  reviewed patients,  in  
addition  to  vaginal  bleeding had abdominal  pain,  
compared  to  1%  in  our  study. Ninety one percent of his   
patients   had amenorrhea  (Figure No.17).  In  this  study  
there  is  under  estimation  of results  which  may  be  due  
to  undetermined  clinical presentation,  mentioned  as  
molar  pregnancy  and equivalent to (32%).   
    Histological  examination  showed  that  molar  
pregnancy  was  the  dominant  diagnosis  (96%)  and  
choriocarcinoma forms 4%  (Figure N0.18).   Locally,  this  
result  typically coincides  with  the  study  of   Sana 
Mustafa44,  in which molar  pregnancy  forms  96%  and  
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choriocarcinoma  4%. Outside  the  country  this  study  has  
the  same  pattern  of studies  done  by  Moodley  M  and  
his  colleagues(39) in South  Africa,  Razieh  Mohammed  
and  her  colleagues(40) in Iran,  Dr.  Sajjanshetty   Shalini(41) 
in  India  and  Aligbe J.u.  and  colleagues(42)  from  Nigeria   
which showed  prevalence  of molar  pregnancy  but  with  
little  variations  in  percentages.  Exceptionally  this  study  
differs  from  a  study  done  in  Nigeria  by  Maram  and  
her  colleagues(38), which  showed  prevalence  of  
choriocarcinoma  (66.7%) followed  by  molar  pregnancy 
(33.3%).   
Detailed  analysis  of  this  study  showed  that  partial  
molar  pregnancy  was  the  commonest  diagnosis  (65%) 
followed  by  complete  molar  pregnancy  (28%),  this 
coincides  with  two  studies  done  in  Nigeria  by  BM,  IU 
Takai  and  their  colleagues(45)  (71%)  and  the  other  by 
Aligbe  J.u. and  colleagues(42)  (47%)  and  also  with  a 
study  done  in  Netherland  by  Charlotte  Lylool  and  his 
colleagues(46)  (44%).  On  the  other  hand  all  these 
studies,   including  our  study,  differ  from  other  studies 
done  by  Mourali M  &  his  colleagues  in  Tunisia(47), 
Razieh  Mohammed  and  her  colleagues(40) in  Iran  and  
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Sajjanshetty Shalini(41)in India, who found that, complete 
molar  pregnancy  was  the  commonest  diagnoses 
(68.15%, 81% and 55.2% respectively).  
Choriocacinoma,  which  comprises  4%  &  represents  the 
third   common  pathology  in  this  study;  this  coincides 
with  Hornlc,  Bilek  K  study  in  Germany(48),  Harma  M & 
colleagues(49) in  Turkeya  and  Aligbe J.u  Ekanem  & 
colleagues(42) in  Nigeria.   But  it  differs  from  Nizam  K & 
his colleagues’  study(50) in Pakistan in which 
choriocarcinoma  was  the  least  common  pathology  and 
SU  Marama  and  her  colleagues(38) in  Nigeria  in  which 
choriocarcinoma  was  the  prevalent  lesion.  Vaginal 
bleeding  was  the  classical  leading  complain  which  was 
typically  similar  to  all  studies.  In  contrast  to  Grimes 
DA(51)  study  in  Nigeria,  abortion  was  not  a  risk  factor  
for  choriocarcinoma.  In  this  study  choriocarcinoma 
exclusively  occurred  in  multipara,  so  it  increases  with 
increased  parity  and  this  coincides  with  the  study  of 
Agboola A  study  in Nigeria(52) (Table No.2)  
 Invasive  molar  pregnancy  was  the  least  common 
pathology  in  this  study  and  so  in   the  studies  of: 
Harma  M  &  colleagues(49)  from  Turkey,  
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Martaadisoebrata D from Indonesia(53), Aligbe J.u  Ekanem 
&  his colleagues(42) from  Nigeria  and  Hornlc,  Bilek  K(48) 
in  Germany.  Invasive mole  was  not  encountered  in  the  
studies  done  in Nigeria  by  BM,  IU &  their  colleagues(44) 
and  SU  Marma &  her  colleagues(38).  In  this  study,  the  
peak  incidence  of invasive  mole  is  in   3rd  decade  grand  
multiparous mothers,  which  typically coincides with, 
Martaadisoebratas’  study(53)  in Indonesia. 
Analysis  of  complete  molar  pregnancy  showed  that  the 
peak  incidence  also  occurred  in  the  2nd  and  third  
decade and  the majority  of  cases   occurred  in  the  2nd  
decade.  This coincides  with  a  study  done  in  Uganda(54)  
by  Dan  K Kaye,  and  with  Thapak  &  colleagues’  study  
in Katmandu(55)  and   also  with   the   study  done  by 
Boufettal  H  &  his  colleague(56).  Patients  in  reproductive 
age  extremities  (over 40 and less than 20 years)  comprise 
44% (22% for each),  which  means  increased  risk  with 
age  extremities,  and  this  is  similar  to  the  last  study  by 
Boufettal  H &  his  colleague  (Table No.3).  
 Table 4 in this  study  showed   that  CHM  was  common  
in  multiparous women  (15 out of 26)  followed  by  grand  
multipara  6  patients ,  especially  in  gravia  between  9-13  
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where  4  cases  occur,  and  then  PG  by  5  cases.  In  
contrast  to  this findings  Boufettal  &  his  colleague(56) 
found  to  be  common  in  para 1  and  PG   while  in  Nepal  
Thapak  & colleague(55) said  it  is  common  in  PG . 
Hysterectomy specimens   were   submitted in 13% of  
cases  of  CHM  (Figure No.19).  This is relatively high  if  
compared  with Thapak & colleagues study  in which  
hysterectomy specimens  form  1.2 %.  This  variation  may  
be  due  to  the  increased  frequency  of  the  disease  
above   40  years  and  the  lack   of  expert  radiologists.  
In  partial  mole  hysterectomy  was  performed  in  6%  of 
patients  (Figure No.20).  This  is  also  high  if  compared 
with   Mourali   M   &   his   colleagues(46).  
Cases  of  placental  site  trophoblastic  tumors ,  placental 
site  nodules ,  epithelioid  trophoblastic  tumors were not  
encountered  in  this  study. This  is  similar  to  studies 
done  by  of  Razieh Mohammed  and  her  colleagues  in    
Iran(40),  Aligbe  J.u. and  colleagues(41) from  Nigeria ,  Tariq  
Kashoggi  in  KSA(43)&  BM,  IU  Takai  and  their  
colleagues(45) from  Nigeria . This result  differs  from  
studies done  in  south  Africa  by  Moodley  M  and  his 
colleagues(39)   who  found  that  2% of  cases were  
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placental  site  trophoblastic  tumors.   Mourali   M   &   his   
colleaguesdone  in  Tunisia  &     Charlotte   Lylool   and   
his  colleagues(46) in   Netherland   both described  less  
than 1% of   placental  site  trophoblastic  tumors.  
Sajjanshetty  Shalini(41)  from  India  described  1.8%  of  
cases  as    placental  site  trophoblastic  tumors  &  8%  as  
placental  site  trophoblastic  nodules . 
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                           4-2-CONCLUSION  
 
· This  study  is  a single  institute  study  so  accurate 
incidence cannot be estimated. But  based  on  this 
study we  can  say  that  GTD  is  not  an  uncommon  
disease. 
· In this study the GTD was higher in the 2nd &3rd 
decades (69%) compared to (11%) in PG & (20%) in 
above 40 age group, so  reproductive  age  extremities 
are not risk factors for GTD as in the literature. 
· The study showed that one third of cases were 
associated with abortion, so it can be considered as a 
risk factor. 
· Because more than half of cases (52%) occur in multipara 
, 31% in grand multipara & 17% in PG, so increased parity 
can increase the risk of GTD especially if there is a 
previous history of abortion.  
· As more than one third of cases (38%) occur in the 
second decade, GTD should be suspected in any 
multiparous lady in her second decade of life, with a 
previous history of abortion presenting with  hyperemesis 
gravidarum in her current pregnancy. 
Please purchase PDFcamp Printer on http://www.verypdf.com/ to remove this watermark.
 ϳϴ 
 
                   4-3- RECOMMENDATIONS 
 
It is recommended that: 
1- Establishment of many specialized centers or units for 
GTD, for management and follow up of patients. 
2- Strict criteria for follow up should be established by 
specialists.  
3- The histopathologic reports should include the advice of 
follow up of the patients by HCG. 
4- Chest X ray shoud be done for patient with 
choriocarcinoma. 
5- Records should be complete. Including maternal history 
of previous abortion especially molar pregnancy and 
ultrasound reports which is essential for proper 
histopathological evaluations.  
6-Cytogenetic analysis is a promising tool in this field and 
it should be included in researches. 
7- During preparation of this study we noticed that most 
patients had no u/s reports, so we recommend that any 
patient with vaginal bleeding must be followed by u/s. 
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No: 
Age: 
Parity: 
Clinical Remarks: 
Type of specimen: 
Microscopic examination: 
- Presence of villi within the uterine cavity or 
deeply within the myometrium. 
- Size of vill:  
A- Enlarged villi of equal in size. 
B- Enlarged villi admixed with small and normal 
size villi. 
- Scalloped borders with trophoblastic inclusions. 
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- Presence of generalized hydropic changes in villi 
with central cistern. 
- Presence of prominent cavitation. 
- Morphology of trophoblastic cells: 
A- Marked hyperplasia of both cyto & syncytio 
trophoblastic cells. 
B- Mild and focal syncytiotrophoblastic cells 
hyperplasia with lacy and moth eaten 
appearance. 
C- Striking cytological a typia. 
D- Highly pleomorphic with a typical mitoses. 
E- Presence of syncytiotrophoblasts 
surrounding cytotrophoblasts. 
F- Presence of extensive hemorrhage ad 
necroses. 
-Evidence of Ftal development: 
          A- Presence of nucleated RBCs in villous 
capillaries. 
          B-  Fetal tissue. 
Histological Diagnosis. 
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Partial mole : chorionic villi with inclusion and cytotroophoblastic hyperplasia (×ϮϬϬͿ H&E 
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      Invasive molar pregnancy: villous within the myometrium (x40) H&E 
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Chrocarcinoma: pleo morphism with atypical miltoses (ǆϰϬϬ)  H&E 
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